Clinical Trials Browser

Breast Neoplasms

NCT00486356 2024-01-03

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Phase 1 Completed

46 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Stomach Neoplasms

NCT00002866 2020-04-01

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Phase 1 Completed

50 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT01386346 2018-12-12

VEOX

Phase 1 Completed

12 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00822848 2018-09-07

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Phase 1 Completed

18 enrolled

Sarcoma

NCT01624441 2018-03-30

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Phase 1 Completed

40 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Phase 1 Completed

111 enrolled

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT00878904 2017-03-24

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00246103 2017-02-23

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

Phase 1 Completed

82 enrolled

Tumor-Agnostic

Neoplasms

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

NCT00322374 2016-03-10

Phase I Combination w/ Epirubicin

Phase 1 Completed

42 enrolled 24 charts

Breast

Breast Neoplasms

NCT00753207 2016-02-15

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Phase 1 Completed

10 enrolled

Breast

Breast Neoplasms

NCT02392845 2015-03-19

MODEL1

Phase 1 Completed

17 enrolled

Breast

Breast Neoplasms

NCT00008034 2012-07-18

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Phase 1 Completed

15 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00020748 2011-03-24

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

VEOX

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Phase I Combination w/ Epirubicin

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

MODEL1

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer